VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
Boston Scientific Corporation vs Fiserv, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Boston Scientific Corporation
BSX · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.
View BSX analysisFiserv, Inc.
FISV · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Fiserv, Inc.'s moat claims, evidence, and risks.
View FISV analysisComparison highlights
- Moat score gap: Fiserv, Inc. leads (67 / 100 vs 65 / 100 for Boston Scientific Corporation).
- Segment focus: Boston Scientific Corporation has 5 segments (49.8% in Cardiology); Fiserv, Inc. has 2 segments (50.4% in Merchant).
- Moat breadth: Boston Scientific Corporation has 6 moat types across 3 domains; Fiserv, Inc. has 6 across 3.
Primary market context
Boston Scientific Corporation
Cardiology
Cardiology devices (interventional cardiology, structural heart, electrophysiology, cardiac rhythm management and remote monitoring)
Global
Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists)
Medical device OEM / implantables + procedure devices + service-enabled monitoring
49.8%
Fiserv, Inc.
Merchant
Merchant acquiring and commerce enablement (SMB + enterprise omnichannel payments, POS, gateway/orchestration, and related software)
Global
Merchants (SMB and enterprise), plus channel partners (ISVs/ISOs/financial institutions) that serve or refer merchants
Merchant acquirer / payment processor / commerce and POS platform provider
50.4%
Side-by-side metrics
Moat coverage
Shared moat types
Boston Scientific Corporation strengths
Fiserv, Inc. strengths
Segment mix
Boston Scientific Corporation segments
Full profile >Endoscopy
Oligopoly
Urology
Competitive
Neuromodulation
Oligopoly
Cardiology
Oligopoly
Peripheral Interventions
Competitive
Fiserv, Inc. segments
Full profile >Merchant
Oligopoly
Financial
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.